GENE & B LTD

Company Registration Number:
13260469 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

GENE & B LTD

Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8

GENE & B LTD

Company Information

for the Period Ended 31 March 2025




Director: ADOMA EUNICE CHEREMEH
Registered office: Flat 147 Rowland Hill House
Nelson Square
London
England
SE1 0LU
Company Registration Number: 13260469 (England and Wales)

GENE & B LTD

Directors' Report Period Ended 31 March 2025

The directors present their report with the financial statements of the company for the period ended 31 March 2025

Principal Activities

BEAUTY PRODUCT/HEALTH & NUTRITION

Directors

The director(s) shown below were appointed to the company during the period
ADOMA EUNICE CHEREMEH
01 April 2024

This report was approved by the board of directors on 9 May 2025
And Signed On Behalf Of The Board By:

Name: ADOMA EUNICE CHEREMEH
Status: Director

GENE & B LTD

Profit and Loss Account

for the Period Ended 31 March 2025


Notes

2025
£

2024
£
Turnover 2,254 0
Cost of sales ( 160 ) ( 0 )
Gross Profit or (Loss) 2,094 0
Distribution Costs ( 1,937 ) ( 0 )
Administrative Expenses ( 65 ) ( 0 )
Operating Profit or (Loss) 92 0
Profit or (Loss) Before Tax 92 0
Profit or (Loss) for Period 92 0

The notes form part of these financial statements

GENE & B LTD

Balance sheet

As at 31 March 2025


Notes

2025
£

2024
£
Fixed assets
Total fixed assets: - -
Current assets
Cash at bank and in hand: 93 1
Total current assets: 93 1
Net current assets (liabilities): 93 1
Total assets less current liabilities: 93 1
Total net assets (liabilities): 93 1

The notes form part of these financial statements

GENE & B LTD

Balance sheet continued

As at 31 March 2025


Notes

2025
£

2024
£
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 92
Shareholders funds: 93 1

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 9 May 2025
And Signed On Behalf Of The Board By:

Name: ADOMA EUNICE CHEREMEH
Status: Director

The notes form part of these financial statements

GENE & B LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

GENE & B LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Employees


    2025

    2024
    Average number of employees during the period 1 1

GENE & B LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 3. Off balance sheet disclosure

    No